- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: RDEA-594 | RDEA594 | Zurampic®
lesinurad is an approved drug (FDA (2015), EMA (2016))
Compound class: Synthetic organic
Comment: Lesinurad is an orally available inhibitor of URAT1, the renal transporter that regulates uric acid excretion from the body [1-2].
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
1. Burns CM, Wortmann RL. (2011)
Gout therapeutics: new drugs for an old disease.
Lancet, 377 (9760): 165-77. [PMID:20719377]
2. Yeh L, Shen Z and Kerr B. (2009)
RDEA594: a potent URAT1 inhibitor without affecting other important renal transporters, OAT1 and OAT 3 [abstract].
Ann Rheum Dis, 68: A320.